{"title":"用于药物发现的戊酰化黄酮类淫羊藿苷和淫羊藿苷:结构修饰和生物活性研究","authors":"Jing Wang, Lu Hou, Ying Lin, Lei Zhang","doi":"10.1007/s00044-025-03426-0","DOIUrl":null,"url":null,"abstract":"<div><p>Prenylated flavonoids icariin and icaritin are the crucial ingredients of traditional Chinese medicinal <i>Herb Epimedii</i>. Icariin is an isoprenoid flavonoid glycoside, and icaritin is the aglycon of icariin. During the past decades, icariin and icaritin have generated a lot of interest in the biological and clinic applications, and icaritin has been an approved drug for advanced HCC in China in 2022. However, poor water solubility, low therapeutic efficiency and poor pharmacokinetic properties are the major obstacles, which had significantly limited their clinical application. Given the pivotal role of icariin and icaritin, this review comprehensively reviews the structural modifications of icariin and icaritin, which might help to provide novel insights for the development of novel derivatives of icariin and icaritin with favorable pharmacological profiles and promising clinical application potential.</p><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"34 7","pages":"1405 - 1420"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prenylated flavonoids icariin and icaritin for drug discovery: structural modifications and bioactivity studies\",\"authors\":\"Jing Wang, Lu Hou, Ying Lin, Lei Zhang\",\"doi\":\"10.1007/s00044-025-03426-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Prenylated flavonoids icariin and icaritin are the crucial ingredients of traditional Chinese medicinal <i>Herb Epimedii</i>. Icariin is an isoprenoid flavonoid glycoside, and icaritin is the aglycon of icariin. During the past decades, icariin and icaritin have generated a lot of interest in the biological and clinic applications, and icaritin has been an approved drug for advanced HCC in China in 2022. However, poor water solubility, low therapeutic efficiency and poor pharmacokinetic properties are the major obstacles, which had significantly limited their clinical application. Given the pivotal role of icariin and icaritin, this review comprehensively reviews the structural modifications of icariin and icaritin, which might help to provide novel insights for the development of novel derivatives of icariin and icaritin with favorable pharmacological profiles and promising clinical application potential.</p><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":699,\"journal\":{\"name\":\"Medicinal Chemistry Research\",\"volume\":\"34 7\",\"pages\":\"1405 - 1420\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00044-025-03426-0\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-025-03426-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Prenylated flavonoids icariin and icaritin for drug discovery: structural modifications and bioactivity studies
Prenylated flavonoids icariin and icaritin are the crucial ingredients of traditional Chinese medicinal Herb Epimedii. Icariin is an isoprenoid flavonoid glycoside, and icaritin is the aglycon of icariin. During the past decades, icariin and icaritin have generated a lot of interest in the biological and clinic applications, and icaritin has been an approved drug for advanced HCC in China in 2022. However, poor water solubility, low therapeutic efficiency and poor pharmacokinetic properties are the major obstacles, which had significantly limited their clinical application. Given the pivotal role of icariin and icaritin, this review comprehensively reviews the structural modifications of icariin and icaritin, which might help to provide novel insights for the development of novel derivatives of icariin and icaritin with favorable pharmacological profiles and promising clinical application potential.
期刊介绍:
Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.